In Brief: FDA Vaccines & Related Biologics Advisory Committee
Executive Summary
FDA Vaccines & Related Biologics Advisory Committee: Safety and efficacy data for SmithKline Beecham's DTaP vaccine (Infanrix) to be discussed at July 10 meeting. The committee will review safety and efficacy data for a liquid version of Merck's Haemophilus influenzae b conjugate vaccine July 11, and also will hear a briefing on proposed changes to polio vaccine recommendations and on research programs in the division of viral products. Both days begin at 8 a.m. at the Holiday Inn, Bethesda, Md...